Risk of hernia-related complications after transjugular intrahepatic portosystemic shunt creation in patients with pre-existing ventral abdominal hernias: 15-year experience at a quaternary medical center
Objective Transjugular intrahepatic portosystemic shunt (TIPS) placement is used to treat the sequelae of portal hypertension, including refractory variceal bleeding, ascites and hepatic hydrothorax. However, hernia-related complications such as incarceration and small bowel obstruction can occur af...
Saved in:
| Main Authors: | Ruth Bell, Sasan Partovi, Michael Rosen, Baljendra Kapoor, Charles McDaniel, Natalie Farha, Catherine Vozzo, Jennifer Bullen, Carlos Romero-Marrero |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-10-01
|
| Series: | BMJ Open Gastroenterology |
| Online Access: | https://bmjopengastro.bmj.com/content/9/1/e000876.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Racial disparities in transjugular intrahepatic portosystemic shunt procedure outcomes
by: Donna Niedzwiecki, et al.
Published: (2022-12-01) -
Transjugular Intrahepatic Portosystemic Shunt Reduction for Medically Refractory Hepatic Encephalopathy
by: Brandon Toliver, et al.
Published: (2024-08-01) -
Transjugular intrahepatic portosystemic shunt with gastric vein embolization in liver cirrhosis
by: V. I. Korobka, et al.
Published: (2024-09-01) -
The Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Current Status
by: Gilles Pomier-Layrargues, et al.
Published: (2012-01-01) -
Treating systemic inflammation by transjugular intrahepatic portosystemic shunt: Editorial on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis”
by: Georg Semmler, et al.
Published: (2025-04-01)